National Medical Research Center of Cardiology, Moscow (Russian Federation)
Follow
Contributor content
Presentation
Efficiency and safety of the modified protocol for cardioversion of atrial fibrillation using the antiarrhythmic drug niferidil. First results of clinical use.
